DAILY UPDATE
 June 13, 2023
Dear Valued Reader,

Karim Rahemtulla is pushing his Trade of the Day Plus newsletter with a story about "defeating China" by preparing for the possible Taiwan invasion by betting on a US supplier of semiconductor equipment -- his special report hints at "The #1 Stock to Woar from 2-Nanometer Chips"... so what's the stock, and what's the story?  Just click below to...

In 2010, the world used a mere 100,000 tons of lithium.

Fast-forward to 2030, the demand is set to skyrocket to 3 million tons — a staggering 30-fold surge.

Imagine this: every day we will devour a month's supply of lithium.  No other metal can boast this explosive growth trajectory.

Lithium battery imports just smashed all-time records. And that’s a big problem…

America's appetite for lithium is insatiable, and the hunt for LOCAL sources is critical.

Get this… an incredible 200+ battery megafactories are slated for construction by 2030.

Operating at full throttle, they will demand thirty-seven times the lithium produced in 2020.

It's high-stakes for lithium investors and companies. Don't miss this unprecedented opportunity.

Uncover the details and companies in this lithium boom by clicking here.
ADVERTISEMENT

Finally we get a little break from AI... though it turns out to be for a stock that's got similar expectations, and some mega growth dreams ahead.  Dr. David Eifrig's Prosperity Investor is being teased with a pitch for the "Ultimate Weight Loss Drug," which he says could be approved within a couple weeks... so what's the story?  Could this be the best-selling drug of all time?  Just click below to...


Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe, its employees, or the author of this email. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. Please note that unsubscribing applies only to receiving emails, if you have a premium membership in the Stock Gumshoe Irregulars that membership will not automatically change or be canceled by clicking unsubscribe. Please contact us if you would like to change a paid membership.